LIVEN announcements Liven Pharma Limited
Liven Pharma Limited (LIVEN) has 100 notices stored from the exchange, from 03 Jul 2025 to 12 Nov 2026. The newest is dated 12 Nov 2026; the titles below are the exchange’s own words.
Every notice stored, newest first
| Date | Kind | Title as filed | |
|---|---|---|---|
| 12 Nov 2026 | General meeting | General Meetings / Briefing Sessions | |
| 12 Nov 2026 | Corporate briefing | Notice of Corporate Briefing Session | |
| 02 Nov 2026 | Financial results | Financial Results for the Quarter Ended September 30-2026 | |
| 27 Oct 2026 | Board meeting | BOARD MEETING FOR 1st Quarter Financials 2027 | |
| 26 Oct 2026 | General meeting | Certified True Copy of Resolution Passed in Annual General Meeting Held 26th October 2026 | |
| 05 Oct 2026 | Report sent to shareholders | Correction Clarification Regarding Annual Report 2026 | |
| 05 Oct 2026 | General meeting | Notice of Annual General Meeting REVISED | |
| 05 Oct 2026 | General meeting | Notice of Annual General Meeting | |
| 05 Oct 2026 | Financial results | financial results for the Year Ended June 30, 2026 | |
| 05 Oct 2026 | Report sent to shareholders | Transmission of Annual Report for the Year Ended June 30, 2026 | |
| 05 Oct 2026 | Regulatory notice | Annual Free-Float Certificate duly verified by the Auditor REVOKED | |
| 02 Oct 2026 | Board meeting | Board meeting in Progress | — |
| 25 Sep 2026 | Board meeting | Board Meeting | |
| 27 Aug 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 15 Jul 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 14 Jul 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 14 Jul 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 24 Jun 2026 | Material information | MATERIAL INFORMATION SIGNING OF MOU WITH TOFFLON THE TECH GIANT OF CHINA | |
| 29 Apr 2026 | Financial results | Financial Results for the 3rd Quarter Ended 31st March 2026 | |
| 23 Apr 2026 | Board meeting | Board Meeting for the 3rd Quarter Financials of 2025-26 | |
| 11 Mar 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Mar 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Mar 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 09 Mar 2026 | Report sent to shareholders | Condensed Interim Financial Statements for the Half Year ended December 31, 2025 (with shariah compliant disclosure) | |
| 27 Feb 2026 | Report sent to shareholders | Condensed Interim Financial Statements for the Half Year ended December 31, 2025. | |
| 27 Feb 2026 | Financial results | Financial Results for the half year ended December 31, 2025 | |
| 19 Feb 2026 | Board meeting | Board Meeting for Accounts for the Period Ended 31st December 2025 | |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 18 Feb 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 20 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 19 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 19 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 19 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 19 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 19 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 13 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 13 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 13 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 13 Jan 2026 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 07 Jan 2026 | Rights issue | Credit of Right Shares into CDS account - Liven Pharma Limited | |
| 05 Jan 2026 | Announcement | Liven Pharma Limited | |
| 02 Jan 2026 | Financial results | Financial results for the quarter ended September 30, 2025. | |
| 02 Jan 2026 | Rights issue | No Objection Certificate (NOC) request for release of rights shares subscription money of Liven Pharma Limited | |
| 02 Jan 2026 | Rights issue | No Objection Certificate (NOC) request for release of rights shares subscription money of Liven Pharma Limited REVOKED | |
| 01 Jan 2026 | Board meeting | Extracts of resolution passed in the board of directors meeting of Liven Pharma Limited - December 30, 2025 | |
| 26 Dec 2025 | Rights issue | Right Shares Subscription Status | |
| 26 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 26 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 26 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 26 Dec 2025 | Board meeting | Board meeting for the consideration of Quarterly accounts for the period ended September 30, 2025 | — |
| 23 Dec 2025 | Corporate briefing | LIVEN | Liven Pharma Limited CORPORATE BRIEFING SESSION | |
| 23 Dec 2025 | Corporate briefing | CORPORATE BRIEFING SESSION | — |
| 23 Dec 2025 | Announcement | Commission of Automation in Ampoule Washing | |
| 22 Dec 2025 | Board meeting | Board Meeting other than financial results | |
| 11 Dec 2025 | Announcement | Liven Pharma Limited | |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 11 Dec 2025 | Shareholding disclosure | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | — |
| 10 Dec 2025 | Announcement | Liven Pharma Limited | |
| 08 Dec 2025 | Material information | Disclosure of Material Information - Commissioning of Automatic Blistering Packing Line Machine | |
| 08 Dec 2025 | General meeting | Certified True Copy of Passed/Adopted in the 34th Annual General Meeting of Liven Pharma Limited | |
| 01 Dec 2025 | Rights issue | DISPATCH OF LETTER OF RIGHTS AND CDC INTIMATION LETTER | |
| 01 Dec 2025 | Rights issue | SCHEDULE FOR HANDLING UNPAID RIGHTS - LIVENR | |
| 01 Dec 2025 | Rights issue | CREDIT OF UNPAID RIGHTS OF LIVEN INTO CDS | |
| 28 Nov 2025 | Announcement | Liven Pharma Limited | |
| 28 Nov 2025 | Rights issue | LIVEN | Liven Pharma Limited Right Issue Subscription Amount Received From Substantial Shareholders and Directors | |
| 27 Nov 2025 | Rights issue | LIVEN | Liven Pharma Limited Issue Right Shares @ 21.496% at Par Value Rs.10/- Each Per Ordinary Share | |
| 25 Nov 2025 | Rights issue | Notice of Declaration of CDS Eligibility of Letter of Rights (Right Entitlements) of Ordinary Shares of Liven Pharma Limited | |
| 18 Nov 2025 | Book closure | Notice of Book Closure - Issuance of Right Shares | |
| 18 Nov 2025 | Rights issue | Right Share - Offer Document | |
| 12 Nov 2025 | Book closure | Notice of Book Closure - Issuance of Right Share REVOKED | |
| 11 Nov 2025 | Book closure | Notice of Book Closure - Issuance of Right Share REVOKED | |
| 06 Nov 2025 | Financial results | Financial Results Summary for Year ended 2025 | |
| 06 Nov 2025 | Financial results | Financial Result For the Year Ended June 30, 2025 | |
| 05 Nov 2025 | General meeting | Notice of Annual General Meeting for the year ended June 30, 2025 | |
| 29 Oct 2025 | Board meeting | Board Meeting For Consideration of Annual Accounts For The Year Ended June 30, 2025. | |
| 02 Oct 2025 | Material information | Material Information | |
| 02 Oct 2025 | Material information | Material Information | |
| 02 Oct 2025 | Material information | Material Information | |
| 01 Oct 2025 | Regulatory notice | LIVEN | Liven Pharma Limited Applied for Extension for Holding the AGM | |
| 12 Sep 2025 | Rights issue | LIVEN | Liven Pharma Limited Declaration of Right Issue | |
| 05 Sep 2025 | Board meeting | LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) - Notice of Board Meeting Of Liven Pharma Limited | |
| 18 Aug 2025 | General meeting | EXTRACT OF RESOLUTIONS PASSED AT THE EOGM OF LIVEN PHARMA LIMITED (THE COMPANY) HELD ON 18.08.2025 ON 11:30AM AT 49 KM MULTAN ROAD LAHORE | |
| 18 Aug 2025 | Report sent to shareholders | Transmission of quarterly Report for the period ended March 31, 2025 | |
| 25 Jul 2025 | General meeting | LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Notice of EOGM | |
| 24 Jul 2025 | General meeting | LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Resolution Passed at the Extra Ordinary General Meeting | |
| 15 Jul 2025 | Board meeting | LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Board Meeting | |
| 03 Jul 2025 | Corporate briefing | LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Presentation of Corporate Briefing Session 2024 |
Titles are the exchange’s own words. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
By kind
- Shareholding disclosure: 37
- Rights issue: 12
- Board meeting: 11
- General meeting: 9
- Financial results: 7
- Announcement: 5
- Material information: 5
- Report sent to shareholders: 5
- Corporate briefing: 4
- Book closure: 3
- Regulatory notice: 2
Counted from the 100 notices above. The kind is set by SuperX’s classifier. Source: the exchange (dps.psx.com.pk), read 16 Nov 2026.
More on LIVEN
- LIVEN share price and overview
- Pharmaceuticals sector
- MACTER announcements · Macter International Limited
- OTSU announcements · Otsuka Pakistan Limited
- SAPL announcements · Sanofi-Aventis Pakistan Limited
- GLAXO announcements · GlaxoSmithKline Pakistan Limited
- ABOT announcements · Abbott Laboratories (Pakistan) Limited
- HALEON announcements · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .